Q2 2018

Source filing unavailable

Q2 2018 · —

Revenue

$3.98M

no prior Q2 2017 on file

Net Income

-$3.16M

no prior Q2 2017 on file

EPS Diluted

-$2.15

no prior Q2 2017 on file

Gross Profit$2,652,000—

Operating Income-$2,666,410—

Margins · derived

Gross margin

Same quarter

no prior Q2 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Castle Biosciences Inc · CIK 1447362 · Engraved from SEC EDGAR